Literature DB >> 4291806

Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D.

R Mittleman, A Chausmer, J Bellavia, S Wallach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4291806     DOI： 10.1210/endo-81-3-599

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  5 in total

1.  Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene.

Authors:  Ana O Hoff; Philip Catala-Lehnen; Pamela M Thomas; Matthias Priemel; Johannes M Rueger; Igor Nasonkin; Allan Bradley; Mark R Hughes; Nelson Ordonez; Gilbert J Cote; Michael Amling; Robert F Gagel
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Ultrastructural evaluation of the effects of calcitonin on bone in thyroparathyroidectomized rats administered vitamin D.

Authors:  S E Weisbrode; C C Capen
Journal:  Am J Pathol       Date:  1974-12       Impact factor: 4.307

3.  Fine structural alterations in thyroid parafollicular cells of cows in response to experimental hypercalcemia induced by vitamin D.

Authors:  C C Capen; D M Young
Journal:  Am J Pathol       Date:  1969-11       Impact factor: 4.307

4.  Effects of glucagon, dibutyryl cyclic 3',5'-adenosine monophosphate, and theophylline on calcitonin secretion in vitro.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

5.  Handling of induced hypercalcaemia in hyperthyroidism.

Authors:  P Lim; E Jacob; O T Khoo
Journal:  Br Med J       Date:  1969-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.